Mingyuan Medicare Development Company Limited is listed on the main board of The Hong Kong Stock Exchange (Stock code: 0233, the “Company") since September 2002. The Company is focused on the development and commercialization of biomedical testing products, and the provision of medical services.With “Care for Health, Passion for Life” as the company motto, the Company is dedicated to developing advanced and popular biomedical testing products for use in health screening and clinical diagnosis for the early detection and prevention of major diseases including cancers. The Company also provides innovative medical services and advanced health management for its customers to raise the public’s awareness on health management. The Company strives to become a leading biochip manufacturer and medical service provider globally particularly in China and to contribute towards disease detection and prevention for all mankind.
